AtriCure, Inc. (ATRC) has 15 SEC Form 4 insider filings on record in the last 90 days. No insider purchases were filed — 8 sales totalling $2.1M. Most recent filing: Sept. 14, 2026.
| Date | Insider | Value | Shares | Stake | Pre-planned | Links |
|---|---|---|---|---|---|---|
| Sept. 14, 2026 filed Sept. 11, 2026 | GROVES REGINA E Director | −$288,071 | 5,313 | −13% | No | |
|
|
||||||
| Sept. 10, 2026 filed Sept. 8, 2026 | Privitera Salvatore Chief Technical Officer | −$201,135 | 3,657 | −2% | Yes | |
|
|
||||||
| Sept. 4, 2026 filed Sept. 2, 2026 | Privitera Salvatore Chief Technical Officer | −$407,558 | 7,763 | −5% | Yes | |
|
|
||||||
| Aug. 26, 2026 filed Aug. 24, 2026 | Dahlquist Karl S. Chief Legal Officer | −$458,099 | 9,370 | −10% | No | |
|
|
||||||
| Aug. 7, 2026 filed Aug. 5, 2026 | Prange Karen Director | −$138,283 | 3,564 | −14% | No | |
|
|
||||||
Showing the 5 most recent of 15 filings in the last 90 days.
Form 4 is the filing company officers, directors and 10% shareholders must submit to the SEC within two business days of trading their own company's stock. Open-market purchases generally carry more signal than sales, which are often scheduled in advance. More on how this works.
Real-time Telegram alerts the moment a Form 4 is filed. Filings shown here are delayed by 72 hours.
Start free